Molecule Details
| InChIKey | RRDCFLPDCXWHHN-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2,4-Diamino-6-[N-(alpha-naphthyl)-N-ethylamino]quinazoline |
| Canonical SMILES | CCN(Cc1cccc2ccccc12)c1ccc2nc(N)nc(N)c2c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.24 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P11166 | SLC2A1 | Homo sapiens | Human | PF00083 | 6.4 | IC50 | ChEMBL |
| P16184 | Pneumocystis carinii | Pathogen | PF00186 | 8.6 | IC50 | ChEMBL;BindingDB | |
| O30463 | folA | Mycobacterium avium | Pathogen | PF00186 | 8.5 | IC50 | ChEMBL;BindingDB |
| O97467 | ht1 | Plasmodium falciparum | Pathogen | PF00083 | 6.4 | IC50 | ChEMBL |
| O61059 | LmGT2 | Leishmania mexicana | Pathogen | PF00083 | 6.3 | IC50 | ChEMBL |